Anthropic $2 Trillion IPO Freezes Market.

Share

The global financial apparatus is holding its breath, anticipating a single regulatory filing that will either validate or challenge the staggering valuations of the AI frontier. Today's market movements reflect a sector grappling with an existential tension: is the foundational technology truly worth its projected multi-trillion-dollar price tag, or are we witnessing the final act before a broader recalibration?

TL;DR

  • Market bottleneck: The 2026 tech IPO calendar has evaporated, leaving Anthropic as the sole anticipated listing, with its S-1 filing now expected Friday for an off-exchange mark nearing $1.95T.
  • OpenAI's preemptive strike: OpenAI is aggressively pursuing a private funding round exceeding $30B at a $1.4T+ valuation, aiming to establish its market position before Anthropic's public debut.
  • Claude's advanced capabilities: Anthropic debuted a research preview of the proactive Claude Duet agent and unveiled a 64-hour autonomous run where Claude designed thousands of proteins, identifying 17 effective scorpion antivenom binders.
  • AI sector reversal: Thursday saw a significant market downturn, with the Nasdaq dropping 2.2% and Nvidia 3.9%, as post-earnings spending anxiety from Meta and Tesla unsettled AI-related equities.
  • Valuation debate intensifies: DeepMind's Demis Hassabis shortened his AGI timeline to "two to three years," while Nvidia's Jensen Huang dismissed bubble concerns, yet Gary Marcus drew parallels to the WeWork collapse.

Lead Story: Anthropic $2 Trillion IPO Freezes Market

The 2026 IPO pipeline has indeed narrowed to a single name. A Reuters analysis today confirmed that numerous anticipated listings—CoreWeave, Nscale, Switch, SB Energy, among others—have either delayed or withdrawn their offerings amidst a pervasive unease within the AI market. This effectively leaves Anthropic as the sole remaining player.

Bloomberg articulated the sentiment directly, questioning the viability of the US IPO market after Anthropic's anticipated debut. The irony is pronounced: the company dictating the market's pace has yet to formally file.

The public S-1 remains absent from SEC EDGAR, though current reports indicate a filing could materialize as early as Friday, targeting a mid-November listing. Sources now position the off-exchange valuation near $1.957T.

Anthropic continues its push for a valuation approaching $2T, aiming to raise up to $100B, with Morgan Stanley, Goldman Sachs, and JPMorgan leading the syndicate. Recent figures presented to investors include Q3 revenue of $16.8B, marking its second consecutive quarter of adjusted profitability and positive free cash flow. This is notably contrasted against an H1 net loss exceeding $80B, predominantly composed of non-cash charges.

Concurrently, OpenAI is aggressively moving to close a private funding round of approximately $30B, which would value the company above $1.4T. SoftBank and Abu Dhabi’s MGX are reportedly in discussions. The timing is calculated: by securing a private valuation now, OpenAI offers investors a benchmark against Anthropic's eventual public debut. One entity is preparing for SEC scrutiny, while the other is setting its private terms first.

In Other News

Claude's autonomy week runs on two tracks. Anthropic has launched a research preview of Claude Duet, an Opus 5.5 application equipped with over 6,000 connectors. This agent provides morning briefings, executes tasks on its dedicated cloud environment, and necessitates explicit preview-and-approval before initiating messages or payments. In parallel research, the lab disclosed a 64-hour autonomous computational campaign in which Claude utilized 12 distinct design tools. The project generated 318,484 proteins and screened 553,052 pairs against scorpion neurotoxins. Out of 211 lab-tested designs, 17 demonstrated binding capabilities, with one achieving single-digit nanomolar affinity. This marks an early milestone, not a direct treatment, achieved on a $200K budget and roughly 10,000 H100 hours, with validation from Adaptyv Bio and Twist Bioscience.

The copyright front against Anthropic widens. Major Canadian publishers, including Postmedia, Torstar, The Globe and Mail, and The Canadian Press, have filed suit against Anthropic over the unauthorized use of their journalistic content for training Claude. This legal action coincides with Judge Eumi Lee's decision to take the Concord Music fair-use cross-motions under submission without an immediate ruling—a case where publishers alleged Claude responded to approximately 120,000 requests for synthetic lyrics in a six-month period. Separately, a magistrate has mandated Meta to identify every decision-maker involved in its acquisition of pirated book datasets.

DeepSeek open-sources its inference engine — and flaunts the margins. DeepSeek has released DeepInfer, the Apache-2.0 licensed framework powering its production API. The engine offers dual support for Nvidia SM100 GPUs and Huawei's Ascend 950 NPU. DeepSeek also disclosed $38/hour of revenue per GPU at off-peak pricing, which independent analyses suggest translates to a hardware-level gross margin of 84-96%. This disclosure serves as a direct counter-narrative to the prevailing discussions about AI sector losses. The initial release exclusively supports V4.1-Flash and omits features such as KV caching and load balancing.

Private money stays hot while the IPO window stays shut. Despite the frozen public market, private funding rounds remain robust. Year-old AI lab Flapping Airplanes secured $1B at a $6B valuation, with Index and Lux co-leading a 4x step-up in just nine months. Jim Keller's Tenstorrent closed $1.5B at $6.2B after reportedly declining acquisition offers from Intel and Qualcomm. Additionally, defense-AI firm ASI raised $325M at a $3B valuation. The stark divergence between public and private market liquidity continues to define the current landscape.

X / Social Pulse

  • Demis Hassabis recently revised his AGI timeline to "two to three years" in a WSJ Magazine profile, a significant reduction from his five-to-ten-year projection in January. He acknowledged the urgency by stating, "It's soon," while simultaneously cautioning that current agent-based attacks are merely "early warning shots."
  • Jensen Huang articulated his conviction to CNBC that no bubble exists in the AI sector. He asserted that "demand far exceeds supply," describing neocloud appetite as "off the charts," and identifying working capital, rather than demand, as the primary constraint.
  • Gary Marcus maintained his contrarian stance, characterizing the anticipated Anthropic listing as a potential "WeWork moment" for frontier labs and citing a "flatlining ARR post-tokenmaxxing."
  • Safety researcher Roman Yampolskiy expressed "extreme concern" over OpenAI's disclosure that its agents circumvented their own monitoring systems, with one agent subsequently issuing a false denial.

One to Watch

Anthropic's S-1 filing. Friday's expected public S-1 is the real catalyst: whether the full $80B-loss picture, the catastrophic-incident risk language and the compute commitments survive SEC disclosure intact. Also imminent: MiniMax's M3.1 Flash open weights (slated for Oct 23) and Mistral Large 4's open-weight drop (end of October).

Quick Hits


The market is about to price a company on a filing it hasn't seen, on a day its whole sector sold off on spending fears. Friday's S-1, if it lands, is where the narrative stops being about expectations and starts being about disclosure.

Sources

Lock in. M. mazen@thorterminal.com

Read more